Phosphorylation on Ser-359 of the α2 Subunit in GABA Type A Receptors Down-regulates Their Density at Inhibitory Synapses
Overview
Authors
Affiliations
GABA type A receptors (GABARs) mediate fast synaptic inhibition and are trafficked to functionally diverse synapses. However, the precise molecular mechanisms that regulate the synaptic targeting of these receptors are unclear. Whereas it has been previously shown that phosphorylation events in α4, β, and γ subunits of GABARs govern their function and trafficking, phosphorylation of other subunits has not yet been demonstrated. Here, we show that the α2 subunit of GABARs is phosphorylated at Ser-359 and enables dynamic regulation of GABAR binding to the scaffolding proteins gephyrin and collybistin. We initially identified Ser-359 phosphorylation by MS analysis, and additional experiments revealed that it is regulated by the activities of cAMP-dependent protein kinase (PKA) and the protein phosphatase 1 (PP1) and/or PP2A. GST-based pulldowns and coimmunoprecipitation experiments demonstrate preferential binding of both gephyrin and collybistin to WT and an S359A phosphonull variant, but not to an S359D phosphomimetic variant. Furthermore, the decreased capacity of the α2 S359D variant to bind collybistin and gephyrin decreased the density of synaptic α2-containing GABAR clusters and caused an absence of α2 enrichment in the axon initial segment. These results suggest that PKA-mediated phosphorylation and PP1/PP2A-dependent dephosphorylation of the α2 subunit play a role in the dynamic regulation of GABAR accumulation at inhibitory synapses, thereby regulating the strength of synaptic inhibition. The MS data have been deposited to ProteomeXchange, with the data set identifier PXD019597.
Tang B, Tang J, Huang Y Int J Mol Sci. 2025; 26(5).
PMID: 40076557 PMC: 11900034. DOI: 10.3390/ijms26051931.
Liu F, Yang S, Shi K, Li D, Song J, Sun L Front Aging Neurosci. 2025; 17:1540019.
PMID: 40071123 PMC: 11893871. DOI: 10.3389/fnagi.2025.1540019.
Lutzenkirchen F, Zhu Y, Maric H, Boeck D, Gromova K, Kneussel M Commun Biol. 2024; 7(1):1635.
PMID: 39668217 PMC: 11638247. DOI: 10.1038/s42003-024-07294-z.
Blednov Y, Shawlot W, Homanics G, Osterndorff-Kahanek E, Mason S, Mayfield J Neuropharmacology. 2024; 257:110035.
PMID: 38876310 PMC: 11387004. DOI: 10.1016/j.neuropharm.2024.110035.
Cho N, Kontou G, Smalley J, Bope C, Dengler J, Montrose K iScience. 2024; 27(4):109512.
PMID: 38715938 PMC: 11075064. DOI: 10.1016/j.isci.2024.109512.